Viriom: Viriom announces NIH/NIAID and Division of AIDS Collaboration with the Long-Acting/Extended Release Antiviral Resource Program

Viriom Inc., a clinical stage antiviral company focused on HIV and viral hepatitis, is developing long-acting versions of its once daily NNRTI inhibitor, elsulfavirine.